Dramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease.

Jessie Risse Damien Mandry Nicla Settembre Charlène Vigouroux Marine Claudin Georgia Tsintzila Olivier Huttin Sergueï Malikov Stéphane Zuily Denis Wahl

Circ Cardiovasc Imaging

From the Vascular Medicine Division, Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases (J.R., S.Z., D.W.), Departments of Radiology (D.M.), Vascular Surgery (N.S., S.M.), Pathology (C.V.), Nuclear Medicine (M.C.), and Cardiology (O.H.), CHRU de Nancy, France; INSERM, U1116, Nancy, France (J.R., S.Z., D.W.); Lorraine University School of Medicine, Nancy, France (J.R., D.M., N.S., D.W., S.M., S.Z.); France; INSERM, U947, Nancy, France (D.M.); Department of Cardiology, CHR de Metz-Thionville, Nancy, France (G.T.).

Published: July 2016

Download full-text PDF	Source
http://dx.doi.org/10.1161/CIRCIMAGING.116.004819	DOI Listing

Publication Analysis

Top Keywords

dramatic response

response tocilizumab

tocilizumab emergency

emergency surgery

surgery severe

severe active

active takayasu

takayasu disease

dramatic

tocilizumab

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!